Cullinan Therapeutics, Inc.

CGEM

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001789972

SEC filings (opens in a new tab)

In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Cullinan Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of CGEM: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	147	2	149	+4
Shares	65.6M	1.37M	64.7M	+457.1K (+0.7%)
Value	$798.8M	$16.7M	$489.6M	−$292.6M (−37.4%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to CGEM in Q1 2025
Institution	Shares	Value	% of portfolio
Nextech Invest, Ltd.	1,141,145	$8.64M	2.01%
Nuveen, LLC	188,030	$1.42M	0.00%
Acadian Asset Management LLC	81,721	$618.0K	0.00%
Perceptive Advisors LLC	80,100	$606.4K	0.02%
Trexquant Investment LP	68,467	$518.3K	0.01%
Graham Capital Management, L.P.	29,505	$223.4K	0.01%
Russell Investments Group, Ltd.	29,363	$222.3K	0.00%
Verition Fund Management LLC	29,175	$220.9K	0.00%
Quest Partners LLC	25,090	$189.9K	0.02%
Dynamic Technology Lab Private Ltd	21,581	$163.0K	0.02%
HRT Financial LP	20,850	$157.0K	0.00%
Palumbo Wealth Management LLC	16,268	$123.1K	0.04%
Oxford Asset Management LLP	15,746	$119.2K	0.05%
Axq Capital, LP	14,255	$107.9K	0.04%
Virtus Investment Advisers, Inc.	13,455	$101.9K	0.03%
Creative Planning	12,950	$98.0K	0.00%
CIBC World Markets Corp	11,597	$87.8K	0.00%
Virginia Retirement Systems Et Al	10,627	$80.4K	0.00%
Prelude Capital Management, LLC	10,152	$76.9K	0.01%
Skopos Labs, Inc.	4,503	$34.1K	0.01%
Farther Finance Advisors, LLC	1,013	$7.60K	0.00%
Larson Financial Group LLC	576	$4.36K	0.00%
Caitong International Asset Management Co., Ltd	401	$3.04K	0.00%
Allworth Financial LP	241	$1.96K	0.00%
Rothschild Investment LLC	245	$1.85K	0.00%
Coldstream Capital Management Inc	207	$1.57K	0.00%
CoreCap Advisors, LLC	29	$220	0.00%

Sold out (23)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of CGEM in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Adage Capital Partners GP, L.L.C.	1,030,438	$12.6M
Boxer Capital Management, LLC	907,895	$11.1M
Foresite Capital Management V, LLC	657,905	$8.01M
Ameriprise Financial Inc	504,264	$6.14M
Springhill Fund Asset Management (HK) Co Ltd	276,400	$3.37M
Sphera Funds Management Ltd.	205,000	$2.50M
Cubist Systematic Strategies, LLC	130,647	$1.59M
BIT Capital GmbH	94,344	$1.15M
E Fund Management Co., Ltd.	74,843	$911.6K
Jump Financial, LLC	66,135	$805.5K
CenterBook Partners LP	43,987	$535.8K
Harbor Capital Advisors, Inc.	30,747	$374.0K
Squarepoint Ops LLC	19,101	$232.7K
State of Wisconsin Investment Board	18,657	$227.2K
Long Corridor Asset Management Ltd	15,000	$182.7K
Qube Research & Technologies Ltd	13,609	$165.8K
Optimize Financial Inc	11,755	$143.2K
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management	11,153	$135.8K
Point72 (DIFC) Ltd	5,986	$72.9K
Virtus ETF Advisers LLC	5,828	$71.0K
Parallel Advisors, LLC	1,317	$16.0K
BFSG, LLC	1,000	$12.2K
Advisor Group Holdings, Inc.	110	$1.34K

Not filed for Q1 2025 yet (2)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEM in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nextech Invest AG	1,141,145	$13.9M
Nuveen Asset Management, LLC	227,033	$2.77M